Range
- - -
Vol / Avg.
-/0.1K
Div / Yield
-
52 Wk
14.96 - 32.1
Mkt Cap
643.9M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.28
Shares
43M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

Related Companies

TickerCompanyChg %Mkt Cap
CMVLFCellectis0%643.9M

Cellectis Frequently Asked Questions

Q

How do I buy Cellectis (CMVLF) stock?

A

You can purchase shares of Cellectis (OTC: CMVLF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cellectis's (CMVLF) competitors?

A

There are no as such competitors for Cellectis.

Q

What is the target price for Cellectis (CMVLF) stock?

A

There is no analysis for Cellectis

Q

Current Stock Price for Cellectis (CMVLF)?

A

The stock price for Cellectis (OTC: CMVLF) is $14.96 last updated Mon May 10 2021 18:30:41 GMT+0000 (Coordinated Universal Time).

Q

Does Cellectis (CMVLF) pay a dividend?

A

There are no upcoming dividends for Cellectis.

Q

When is Cellectis (OTC:CMVLF) reporting earnings?

A

Cellectis does not have any upcoming earnings scheduled.

Q

Is Cellectis (CMVLF) going to split?

A

There is no upcoming split for Cellectis.

Q

What sector and industry does Cellectis (CMVLF) operate in?

A

Cellectis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.